An Integrated Tool Kit for the Clinical Evaluation of Microbial Detection and An...
An Integrated Tool Kit for the Clinical Evaluation of Microbial Detection and Antibiotic Susceptibility Point of Care Testing Technologies
The TEMPOtest project proposal addresses the need to design integrated tools for closing the gap between microbiological point-of-care technologies and actual clinical need, by designing, developing and implementing a microbiologi...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
RAPID
Rapid Antimicrobial susceptibility testing and phylogenetic...
150K€
Cerrado
SCENT
SCENT Hybrid Gels for Rapid Microbial Detection
2M€
Cerrado
FAST-bact
A novel fast test for antibiotic susceptibility testing for...
4M€
Cerrado
RAPP-ID
Development of RApid Point-of-Care test Platforms for Infect...
16M€
Cerrado
RAPP-ID
Development of RApid Point of Care test Platforms for Infect...
16M€
Cerrado
BADGER
calScreener an innovative device for Bacterial Analysis a...
71K€
Cerrado
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
The TEMPOtest project proposal addresses the need to design integrated tools for closing the gap between microbiological point-of-care technologies and actual clinical need, by designing, developing and implementing a microbiological point-of-care tool-kit comprising i) a survey providing information on Europe-wide demand for point-of-care microbiological tests, ii) an archive of freely available quality control/quality assurance microbiological test samples for rapid evaluation of point-of-care microbiological tests, iii) a freely available Comparison Tool comprising specimen archive/software tool to rapidly determine sensitivity, susceptibility, reproducibility and time to diagnosis for new microbiological point-of-care technologies compared to current routine clinical microbiological protocols, iv) the optimization and development of electronic nose and antimicrobial resistance gene microarrays as future technologies for microbiological point-of-care testing and v) the development of supporting database and internet facilities.